Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Iran sends proposal for negotiations with US to mediator Pakistan
Iran threatens painful response if US renews attacks
Ukrainian drones hit Russian port of Tuapse for the fourth time
Detained Myanmar ex-leader Suu Kyi to meet legal team this weekend
